" class="no-js "lang="en-US"> Emma Walmsley - Medtech Alert
Monday, June 16, 2025
Emma Walmsley

Emma Walmsley

About Emma Walmsley

Emma has been GSK CEO and Board Director since April 2017. Emma has been a member of the GSK Leadership Team since 2011, as the President and then CEO of GSK Consumer Healthcare.

Prior to joining GSK in 2010, Emma worked with L’Oreal for 17 years in global and local marketing and general management roles in Paris, London, New York and Shanghai.

Emma joined the Microsoft board as an independent director in 2019. She was previously a Non-Executive Director of Diageo plc. She is a Member of the Stanford Medicine Board of Fellows.

Emma is a business advisor to the UK Prime Minister and a member of The Business Council Executive Committee in the US.

Emma ranked top in Fortune Magazine’s 2020 ‘Most Powerful International Women’.

Emma was appointed Dame Commander of the British Empire for services to the pharmaceutical industry and business in 2020.

Emma holds an MA in Classics and Modern Languages from Oxford University.

Related Story

Iain Mackay, Chief Financial Officer, to Retire From GSK, Julie Brown Appointed as Successor

September 27 2022

GSK plc (LSE/NYSE: GSK) today announced that Iain Mackay, Chief Financial Officer (CFO), has decided […]